Azenta, Inc. (AZTA)
- Previous Close
51.34 - Open
51.25 - Bid 50.80 x 100
- Ask 50.88 x 200
- Day's Range
50.42 - 51.47 - 52 Week Range
41.20 - 69.16 - Volume
378,863 - Avg. Volume
480,574 - Market Cap (intraday)
2.743B - Beta (5Y Monthly) 1.51
- PE Ratio (TTM)
-- - EPS (TTM)
-2.72 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 2, 2021
- 1y Target Est
62.60
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
www.azenta.com3,400
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: AZTA
Performance Overview: AZTA
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AZTA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AZTA
Valuation Measures
Market Cap
2.74B
Enterprise Value
2.00B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.59
Price/Book (mrq)
1.23
Enterprise Value/Revenue
3.06
Enterprise Value/EBITDA
31.73
Financial Highlights
Profitability and Income Statement
Profit Margin
-23.12%
Return on Assets (ttm)
-1.55%
Return on Equity (ttm)
-5.95%
Revenue (ttm)
651.76M
Net Income Avi to Common (ttm)
-152.26M
Diluted EPS (ttm)
-2.72
Balance Sheet and Cash Flow
Total Cash (mrq)
821.71M
Total Debt/Equity (mrq)
3.34%
Levered Free Cash Flow (ttm)
43.53M
Research Analysis: AZTA
Company Insights: AZTA
AZTA does not have Company Insights